A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis
Clinical trial NCT03718299 · COMPLETED
Trial details
- NCT number
- NCT03718299
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-16
- Primary completion
- 2021-11-02
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.